iWalk, Bedford, Massachusetts, announced that it has closed a $17 million private Series D equity financing round (the fourth stage in the seed stage financing cycle of a new business growth, generally for financing a special situation). The funding will primarily be used to further develop and commercialize a series of innovative personal bionics products, expand the company’s global sales, and support infrastructure, iWalk said.
The financing was led by new investor Gilde Healthcare Partners, Utrecht, the Netherlands, an international investment firm with $600 million under management, focusing on the healthcare sector; Geoff Pardo, a partner at Gilde, has concurrently joined the company’s board of directors. Existing investors, including WFD Ventures, New York, New York; General Catalyst Partners, Cambridge, Massachusetts; and Sigma Partners, headquartered in Boston, Massachusetts, also participated in the financing round.
